logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Medicine (01276.HK) spent approximately 18.31 million yuan to repurchase 270,000 shares of A shares on September 4th.

date
05/09/2025
Wise Finance APP News, Hansoh Pharmaceutical (01276.HK) announced that it will spend approximately 18.31 million yuan to repurchase 270,000 A shares on September 4, 2025.
Latest
2 m ago
Hengrui Pharmaceutical (01276) intends to license the first innovative drug project, HRS-1893, to Braveheart Bio for a fee to expand into overseas markets.
4 m ago
According to reports, the chip jointly designed by OpenAI and the American semiconductor giant Broadcom will be shipped next year.
5 m ago
Huakang Life Sciences (08622.HK) shareholders have deposited their stocks into Zhonghao Securities with a market value of 49.50 million Hong Kong dollars.
5 m ago
China United Development Holdings (00264.HK) shareholder transferred the shares from DBS Bank to Guotai Junan Securities. The market value of the transferred shares is 3.56 billion Hong Kong dollars.
5 m ago
Highland Group (01676.HK) shareholders have transferred their stocks from Zhongtai International Securities to Yuanku Securities, with a transfer value of HKD 4.6077 million.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.